Thomas Bird's practice focuses on intellectual property law, including trademark and design patent disputes, and complex commercial litigation. Thomas has experience in all phases of litigation, including fact and expert discovery, motion practice, settlement, and trial. He also maintains an active pro bono practice.
Thomas earned his J.D. from New York University School of Law, where he was Executive Editor on the Journal of Legislation and Public Policy. He also graduated from Washington University in St. Louis with a B.A. in Philosophy-Neuroscience-Psychology.
- Prominent wine and spirits suppliers, in trademark arbitration, obtaining favorable decision confirming validity of clients’ trademark registrations, granting all of clients’ requests for declaratory relief, and rejecting all of opposing party’s claims of ownership.
- Well-known luxury goods company, in litigation alleging infringement of client’s design patents, false advertising, and unfair competition.
- AstraZeneca, as national counsel in multidistrict litigation involving proton pump inhibitors, Prilosec and Nexium.
- Bayer, as national counsel in multidistrict litigation involving fluoroquinolone medications, Cipro and Avelox.
"Ones to Watch" — Litigation: Intellectual Property Law (2024)
"Ones to Watch" — Product Liability Litigation: Defendants (2023)
- J.D., New York University School of Law, 2016
- B.A., Philosophy-Neuroscience-Psychology, Washington University in St. Louis, 2013, summa cum laude
- New York